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under baseline m~ditions and during isosorbide di~it~te 
In patients with chronic coronary artery disease and left 
ventricular dysfunction the detection f viable hi~rn~ting 
m~~rdium in asynergic territories is important for indicting 
their functional outcome after revascularization (1,2). The 
recognition of a significant ~streva~ularizakion functional 
improvement i  asynergic territories i the true reference 
standard for establishing the presence of hibernating myocar- 
dium. Therefore, it is also the most reliable way to test the 
aecuracy of diagnostic methods used to evaluate myocardial 
viability. At present, the detection of an intact glucose metab- 
olism in hypoperfused areas (perfusion/metabolism mismatch) 
by positron emission tomography is considered the most 
reliable imaging method for assessing myocardial viability 
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(3-5). However, the most widely used metbo 
tion of thallium-201 uptake using late redistribution r rest 
injection imaging (6-11). Although both methods are effective, 
they have important limitations. positron emission tomography 
is expensive and confined to relatively few laboratories. 
Thallium-201 is not as reliable as positron emission tomogra- 
phy, mainly because of false negative r sults (4,5). 
Several experimental studies (12-21) have demonstrated 
that the features of technetium-99m sestamibi are favorable 
for its use as a viability tracer. However, other eports (22-27) 
have suggested that in humans, rest echnetium-99m sestamibi 
underestimates heextent of viable myocardium compared 
with positron emission tomography and thallium-201 imaging. 
More specifically, two studies (26,271 have suggested that 
segments with abnormally ow technetium-99m sestamibi up 
take may recover function after revascularization. However, 
taking technetium-99m kinetics into account, i  is eivable 
that interventions capable of increasing coronary during 
the tracer uptake could improve itsdetection ofviable myo- 
cardium. Several reports (28-38) indicate that short-term 
nitrate administration increases coronary flow by means of 
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s. It has been also de 
P uptake in hypoper- 
basis of their clinical condition, il
ded nitrate therapy for 
at least 48 h before the beginning of the study. Ali other 
apies were continued, and the dition of the natients 
ained unchanged until the st was completed. The 
the execution of ~vo-~inlensional echocar- 
diograpby to assess regional wall motion and hvo technetium- 
99m sest;mibi studies, one at baseline conditions aad the other 
after short-term administration f isosorbide dinitrate. During 
technetium-99m sestamibi injection for baseline scintigraphy, 
first-pass radionuc~ide angiocardiography was acquired to es- 
timate global left ventricular function. T 
studies were p rformed in ran om sequence, 24 h apart, after 
overnight fasting. Ali patient nderwcnt coronary angiogra- 
phy within 2 weeks of the scintigraphic studies. Global and 
regional eft ventricular function were again assessed with 
first-pass radionuclide angiocardiography and two-dimensional 
echocardiography, respectively, at least 3 months after the 
execution of coronary artery bypass grafting or at least 1 month 
after coronary angioplasty. All patients gave informed consent 
to participate in the study. The study protocol was approved by 
the ethics committee of our institution. 
Coronary an&graphy. Selective coronary angiography 
was performed using the Judkins or Sones technique. Cinean- 
giograms were evaluated on the basis of the agreement of two 
observers who had no knobledge of the clinical and scinti- 
graphic data. Lesions that reduced lumen diameter ~50% 
were considered significant. Collateral circulation was sessed 
and scored in four grades (collateral index) from 0 = none to 
lete filling of the epicardial vessel through collateral 
flow (38,41). 
Echocardiography. Two-dimensional echocardiography 
was performed using an Aloka SSD-870 echocardiograph with 
2.5- to 3.5~MHz transducers. Parasternal long-axis, parasternal 
rni~ventr~c~~a~ levels and 
views were o~~a~~~~ and 
ventricle was divided into 13 
segments ~ante~~sept~~, anterior, anterolateral, posterolateral, 
ste~~media~, posteroseptal) were evaluated both at a basal 
mi~ventric~~a~ level in ~~d~iion to a single apical segment. 
Seven segments were attributed to the left anterior descending 
coronas, two to the left circnm ex coronary artery and four a0 
ght coronary artery. 
otion was visually analyzed by two in 
d no knowledge ofclinical, ang 
ings. The following scoring sy
hypokinesia (clearly reduced systolic 
wall thickening and inward motion); 3 = akinesia (absence of 
systolic wall t~~~ckening and motion); 4 = dyskinesia (sy 
Wall ~~1~~~I~j~~ and outward motion). A segment was cidssi 
cast 50% of its total area exhibited abnormal 
le wall motion index was cakulated for each 
as the sum of the scores of all the included 
scgmcnts divided by the number of segments (43). repan- 
d~onnc~ide angiocard~ogra~~~y was acquired in the 30” right 
projection with the patient supine, using an 
gamma camera equipped with a low energy 
all-purpose collimator and using a 20% window CP 
140-keV photopeak of technetium-99m. Twenty- 
ies (925 ABET of technetium-99m sestamibi 
through an indwelling cannula inserted into an antecubital vein 
of the right arm, followed by a booster flush of 20 ml of saline 
solution. The study was acquired in frame mode, using a X2 
zoom factor and an electrocardiographic gating. Left ventric- 
ular ejection fraction was calculated twice from the back- 
ground-subtracted ime-activity curve. The diflerence between 
the two measurements never exceeded two ejection fracrllIn 
units, and the mean value was used for the data analysis. 
~~t~at~ test. Ten milligrams of isosorbide dinitrate diluted 
in 100 ml of isotonic saline solution was administered over 
20 min. Heart rate an< blood pressure were controlled 
throughout the who!c test. Technetium-99m sestamibi was 
injected after 15 min of infusion or earlier if there was a 
decrease in systolic blood pressure >2O mm 
formed, as described next. 
ses~amjb~ sc ~~~g~a~~y. The technetium- 
99m sestamibi dose was 25 mCi (925 MBq) for both baseline 
and the nitrate studies, and was injected while the patient was 
supine. Single-photon emission computed omographic collec- 
tion was performed 60 min later using an Elscint Apex %‘4 
gamma camera equipped with an ultra-high resolution dli- 
matur with a 20% window centered at the 14O-keV photopeak 
of techuctium-99m. The gamma camera head rotated in step 
and shoot mode over a 180” arc from the 45’ right anteriO 
oblique to the 45” left posterior oblique view, with 60 pro&- 
tions of 20 s each. hdgt3 were collected With a X1.4 ZOOm 
factor and stored on 64 x 64 matrices. Image reconstruction 
was performed using backprojection without a preprOcessi% 
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filter and with a Wiener reconstruction filter (dumping factor 
1, full-width alf-maximum 8 mm). No attenuation r scatter 
correction was used. The transaxial slices were realigned along 
the heart axis. 
For the quantitative evaluation f the tomographic images, 
the short-axis slices were used (44). Their count profiles were 
generated by computer software and plotted onto a two- 
dimensional polar map. The count profile of each study was 
compared with a gender-specific data base of rest echnetium- 
99m sestamibi studies prformed in normal control subjects. 
The lower limit of the normal range was et at 2.5 SD below the 
mean value of the gender-specific control group (44). The 
extent of the abnormally ow uptake was first expressed as a 
ent of the entire left ventricular wall. The quan 
r map wtls then divided into three t~rrit~~ries corr~ 
to the distribution of the cor~n;~~ arteries. A separate 
ysis was performed for each territory, and to be considered 
significant, a defect had to be >i2% uf the left anterior 
descending and left circumflex coronary artery territories and 
>$%I of the right coronary artery territory (45). Finally, the 
baseline and nitrate studies were directly ~mpare~, and the 
ch s in both global and individual coronary perfusion 
de were xpressed as a percent of the extent of the defect 
at baseline. 
Follow=~p ~~t~o~. To determine the extent of revascu- 
larization, regional left ventricular function was evaluated. An
asynergic vascular territory was considered tobe improved 
when the wall motion score index decreased >22% after 
revascularization c mpared with the prerevascularizatioa 
value (43). The vascular territories that showed areduction i
wall motion score index after eva~ulari~atiu~ wereconsid- 
ered to be hibematitg territories that exhibited no changes 
were defined asfihrotic. On this basis patients were classified in 
two groups: group A, patients with postrevasc~larization re- 
gional (in at least one asynergic territory) functionai recovery; 
group B, patients without recovery. 
Results are expr~~d a; mean value t
~~metric analysis ofvariance (Tuscan-Willis 
one-way analysis by ranks) was used for the intragroup and 
intergroup data er;rmperison. The comparison of proportions 
was made using the Fisher exact test. The relation between the 
changes induced by the nitrate test and the results of the 
re~~ulariz~tion procedures was analyzed using linear egres- 
sion and the Spearman rank correlation coefficient. A proba- 
bility value p < 0.05 was considered significant. 
One patient presented with a perioperative in-
farction and hence was excluded from any further data analy- 
sis, Data nalysis includes the findings in19 patients (Table 1). 
The presenting symptoms were effort angina nd effort dys- 
pma in 13 patients, effort angina in 3 and effort dyspnea in3. 
According tocoronary angiography, 3 patients had one-vessel, 
5 had two-vessel and 11 had three-vessel coronary artery 
disease. Of the 46 territories supplied by stenotic arteries, 24 
Table 1. Demographic andAngiographic Date of the 19 
Study Patients 
R No./ Age IllfXCt Lcx RcA 
Gender iyr) Site LVEF (a) @) @) 
62 Ant 





50 Ant + Inf 
71 Inf 











41 1 80 75 
34 NO IOU 
49 1 75 100 
30 90 SO 100 
29 I 0 0 
23 1 7s 1 
46 1 90 1 
40 90 0 100 
26 0 75 100 
2S 90 99 90 
30 9s SB 90 
27 90 90 90 
$8 90 7S 90 
19 IiN 0 100 
32 541 0 75 
48 IO0 0 0 
49 SO 75 IO0 
34 90 SO D 
35 0 90 0 
Ant = anterior: F = female; Inf = inferior; LAD = left aetcrior descending 
eoroniiry artery; LQ = left circumflex coromary artery: LVEF = left ventricular 
ejeclion fraction; M = mate; pt = patient: RCA = right coronary artery. 
ically identifiable collateral c~~cu~~tio~, and 
6, 11 and 5 bad collateral indexes of 1, 2 and 3, respectively. 
5 were the site of a previous 
immediately contiguous to the infarcted ones. Nonethe 
of these 22 noninfarcted asynergic areas were also supplied by 
critically stenotic coronary arteries. The prerevascularization 
mean wall motion score index of the abnor 
2.3 9 0.6. The prerevascularization mean left ventricular 
resting ejection fraction was 35.3 f: 10%. 
Fo~~~w-~~ findings. Complete revascularization was ob- 
tained using multiple coronary artery b pass grafting in 15 
patients and coronary angioplasty of all stenosed vessels in 4. 
The postrevascularization mean left ventricular rest ejec- 
tion fraction was 35.4 4 11% (p = NS vs. prerevasculariza- 
tion). The postrevascularizatinn mea  wall motion score index 
of the abnormal territories was 2.2 -C 0.7 (p = NS vs. 
prerevascularization). Of the 45 asynergic vascular territories 
demonstrated before revascularization, 11 showed a reduction 
in wall motion score index after intervention (from 2.2 i- 0.4 to 
1.5 Z!Z 0.3, p < 0.002) and were considered to have been 
hibernating, whereas 34 showed no changes (2.4 + 0.6 both 
before and after revascularization) a dwere classified as 
fibrotic. All 11 hibernating territories were found in 7 patients 
(at least one hibernating territory in e?ch of them) who were 
classified as group A, these 7 patients also showed an ejection 
fraction improvement. Of the 34 fibrotic vascular territories, 4 
were found in the group A patients and the remaining 30 in the 
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.$F w 53.3 c 6.7 54.7 r- 7.9 NS 
Infarct age (mo) 37.8 lr 44.3 96) i 64.1 NS 
CAD (no. of diseased vessels) 2.7 -c 0.8 2.3 ? 0.8 NS 
Presenting ~m~toms 
Effort dy;pnea nd angina 6 7 NS 
EtIort dyspnea 1 2 NS 
Effort angina 0 3 NS 
Collateral score 3 - 1.15 2 + 1.47 NS 
LVEF (%) 36.8 t 10.4 34.4 2 9.9 NS 
WiVISl 2.2 -c 0.3 2.4 + 0.3 NS 
Data presented iWC IllCilll KIllN? i: 
COrOflillgr artcry disease; LVEF = left vcn;~~cM~r ejection fraction; WMSl = wall 
molioa score index (mean ViIlUC for each patient). 
~atie~¶ts who were classified as 
an ejection fraction ~mprove~~e~t. 
iables of the two 
rent in terms of 
.3 vs. 2.4 t 0.3) or collateral score 
On the contrary, the mean e 
coronary artery was greate e 
11 b~bcr~at~~g than in the 34 fibrotic vascular territories 
(91.8 + 15.8% vs. 194.2 + 36.40/o, p < 0.05). 
After revascularization, groups A and B were s~g~ifica~t~y 
different in terms of left ventricular global ejection fraction 
NITRATE TECHNETItJM-YYm SESTAMlBl BMAGlNG 125 
(group A43.4 f 9.47 0, group B 30.8 -C 8.4%, p < 0.02) as well 
efect was observed in 
11 hibernating areas was not significantly different from that of 
nitrate infusion was performed in all patients witbo~t adverse 
action. Technetium-99m sestamibi was injected after 1.5 min in 
15 patients; inanother 4, the injection was 
systolic blood pressure decreased >20 mm 
baseline and nitrate myocardial scintigraphi 
Figures 1 and 2. The results of nitrate p 
individual patients are shown in Table 3. 
%n al% of the patients, the mean extent of ahe global 
efects in the nitrate technetium-99m sestamibi 
images was 28. 15.5% of the left ventricular wall (p = NS 
vs. baseline). owever a recogkablc decrease (ranging 
‘Fubk 3. Results of Tec~~~et~ut~-~91~ Sestattribi Imaging 
Total Extent LAD Extent LCx Extent RCA Extent 
Pt No. Baseline ISDN Baseline ISDN Baseline ISDN Baseline ISDN 
1 32.4 27.8 57.6 50.1 3.5 0.7 0 0 
2 35.1 22.7 36.4 27.6 6.8 3.6 48.7 24.8 
3 15.2 9.2 17.5 4.6 1.3 0.1 14.8 24.9 
4 45 31.8 42.8 24.4 18.7 14.6 76 73.9 
5 37.3 26.8 65.7 52.9 2 0 0 0 
6 12.4 2.1 12.2 2.1 12.6 u 9.3 0 
7 38 25.7 56.4 34.1 0 0 43.5 41.3 
8 14.5 13.9 2.3 5.2 0 0.4 17 51.4 
9 18 18.4 1 1 19.8 7.2 66.3 67.3 
10 52.9 53.1 38.6 38.7 73.6 77.7 9s 94. I
11 38.4 41.8 25.9 27.7 64.8 63.9 35.4 53.8 
I2 36.1 37 6.9 9.2 55.8 57.4 94.6 96.4 
13 15.7 18.5 2.3 1.5 2.4 8.2 6X.0 12.5 
14 69.1 65.6 82.8 78.5 14.4 6.7 90 91 
15 27.9 30 3.6 3.4 88.6 91.1 54.7 65.4 
16 11.2 13.9 22.4 25.5 0 0 II 0 
17 27.1 29.4 1.2 1.5 56.5 57.5 84.4 88.4 
18 43.6 44.9 79.1 78.3 06 0.5 0.2 2 
19 21 20.9 0 0 88.3 88.3 34.4 33.8 
- 
Extent is expressed in percent of the entire left ventricular wall (= total extent) and the individual coronary artery 
territories. ISDN = isosorbide dinitrate; other abbreviations a  in Table 1. 
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n 1. Technetium-!&n sestamibi images from Patient 4. Up 
pray& polar map c&plays. Iat3 map represents myocardial count 
distribution under baa&e anditians, ran 
studies, respectively. A clear reduction in abnormnl territories can be 
observed from ~NX (I) to buse, us shown in lower left imag~~s 
(midventricular vertical long-axis slice). 
from 4% to 83%) was okserved in nine patients, seven of whom 
were in group A. In group A patients, the mean extent of 
global perfusion defect decreased (from 30.8 -C 12.2% to 
20 9 2 I IQ, p = 0.06). However, in the rernai~i~~ 10 patients. 
ail of whom were in growp there was a slight worsening of 
the extent of the defect in the nitrate images. Thus, in group B 
in its entirety, the global extent of the uptake defect was not 
significantly modified in the nitrate images (32.3 5 16S% vs. 
baseline 31.3 -C 17.5%, p = NS). The difference inextent of 
perfusion changes (expressed as percent of the baseline value) 
induced by the nitrate test in the two groups was significant 
(group A, -37.4 Z 21.6% vs. group B, +5.8 -C 8.4%, p < 
0.0005) (Fig. 3). The changes in global extent of the perfusion 
Picks 2. Technelium-YBm sestamibi images from Patient 19. Same 
image disposition as in Figure 1. The lack of any change in the 
isoliurbide &nitrate (!SDN) study compared with abae at baseline can 
be readily nppreciate(l 
defect induced by the nitrate test and the changes in global 
ejection fraction after evascularization appeared tobe corre- 
lated (Pearson r = -0.94, SEE 7.6, p < O.OOOOOt ; Spearman 
rank correlation coefficient -0.9, p < 0.0001) (Fig. 4). 
A significant decrease in the extent of the single-area 
perfusion defect after nitrate administration was observed in
14 territories; 10 territories were among the 11 hibernating. In 
the remaining four territories, postoperative wall motion score 
index remained unchanged. One territory with no reduction i
extent of perfusion defect during the nitrate test had a 
postoperative mprovement i  wall motion. In the 11 hibernat- 
ing territories, the baseline xtent of the perfusion defect 
decreased to 21.4 5 19.1% with nitrate imaging. In the 34 
fibrotic territories, the mean extent of the uptake defect was 
not influenced by nitrate administration (46.6 z 33.8%). Thus, 
with nitrate imaging, the mean extent of the perfusion defect in 
the hibernating territories was significantly smaller than that in 
the fibrotic ones (21.4 + 19.1% vs. 46.6 -‘_ 33.8%, p < 0.05). 
BBS6 ET A_. 
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l28V 
The study was designed to rest whcthcr the short-&c:sna 
i~ern~tti~~~ myocardium. The study rationale. was twofold. 
irst, the favorable influence of nitrates on coronary blood 
QW, ~rt~cu~ar~y in the case of short-term administration, has 
been previously ex~~~~ited in the evaluation of asyn 
hypoperfused territories (3~,39,4~,4~,4~~. Second, rno 
imental data support the use of technetiutn-99tn sesPa 
myocardium ( E-21). 
ood Bow. Regional blood 
inistration of snb~~i~~~al or 
intravenous nitrates, espscially in areas of reduced coronary 
flow (28,30). It has been de~lollstrated (31-33) that nitro- 
glycerin and isosorbi e dinitrate dilate -70% of signiticant 
coronary slenoses. In both experi ental and human studies 
-201 perfusion defect size after nitro 
patients with coronary occh~sion a 
rnyocardial region 
was explained by the i ~roveme~t in coronary collateral 
~~~~~~~~~ to stud 
estimate of contractile reserve i ypokinetic or akinetic left 
ventricular regions after short-te nitrate admi~~strat~o~ was 
used to identify viab e ~lyocardi~m (46,47). The ~n~ct~ona~ 
i~~~~ove~~e~t after nitro~~yce~i~ admi~~stratioR has been re- 
lated to the hemodynamic effect of cardiac de&ding as weI1 as 
e e~~~i~iceiK~e6~t of regional 
this context, collateral circulatio 
ccntly, nitrntc ~ld~~inistration ha 
with ~~~~l~~i~fli-2~~ myocard~al scjfltj~rap~~y to improve the 
detection of viable myocardium (39,40). These ~re~~rn~~a~~ 
at nitroglycerin ad~~inistrat~o~~ before 
could enhance its uptake in areas with 
i&y tracer. Previous 
ental animals (“12,14,16) have shown 
of technetium-99n-6 sestamibi is m 
related to coronary blood flow. However, cell membrane 
integrity and cellular v 
conditiorls fur technet 
(1,3,16,18,20). Wrthe , infarcted myocardium has been 
own to be unable to extract the tracer (17). In a model of 
reperfusion after prolonged occlusion, Sinusas et al. (19) 
demonstrated a significantly lower technetium-99m sestamibi 
uptake compared with microsphere reperfusion flow; this 
rcflccted the decrease in viable tissue. Similar data were 
reported by Freeman et al. (21). 
All &SC data suggest that technetium-9Ym sestakbi could 
r= - 0.94,SEE = 7.6,~ *c O.QQOOOl 
Spearman's=-0.90,pc0.0001 
Figure 4. Correlation between the nitrate-induced 
change (percent of baseline value) in the total 
extent of perfusion and the postrevascularization 
change (percent of the prerevascularization value) 
in left ventrUdr ejection fraction (EVEF). 
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be an excellent viability tracer. However, the results of the few 
available human studies were rather disappointing. ROCCO et
al. (22) found that regions with a severe reduction in tracer 
uptake at rest may Still contain viable myocardium, as Shown by 
the persistence of wall motion. Using positron emission tOmO- 
graphic metabolic imaging, Altehoefer et al. (23) demon- 
strated a partially or even totally preserved glucose metabolism 
in half of the regions with rest technetium-99m sestamibi 
perfusion defects. Cuocolo et al. (24) found a significant 
thallium-201 uptake in regions with decreased technetium-99m 
sestamibi activity. Dondi et al. (25) showed that a 3-h delayed 
study after thallium-201 rest injection detected a higher num- 
ber of rcvrrsiblc defects than rest technetium-99m sestamibi 
arzullo et al. (26) demonstrated that seg- 
rmally low ~reo~r~tive rest technctium- 
99m Scstamibi uptake had u functional recovery atrer evaScu- 
lariiation and that the rate of false necrotic segments wa
g technetium-urn sestamibi than usin 
According to 
an increase in 
technetium-99m seStamibi uptake in part of the baseline 
hypoperfuSed t rritories, whereas in the majority, no nitrate- 
could be demonstrated. A clear elation Seems 
to be present between the detection of a increased tracer 
uptake in nitrate imaging and the recognition of functional 
recovery after evascularization. The patients were allocated to
iwo groups according topostrcvascularization outcome. With 
the exception of the results of technetium-urn sestamibi 
imaging after isosorbide initrate, none of the variables cxam- 
ined could have distinguished between the two groups preop 
eratively. 
Moreover, analysis of the vascular te ritory data sup 
the relation between ~st~evascularization recovery and the 
decrease in extent of the perfusion defect in t~chfl~tium-urn 
xstamibi nitrate ima$ing. The two groups of vascular tenito- 
ties (those with ~tr~v~~ul~ri~ation improvement ihat in- 
clude hi~rn~tin~ tissue and those with unch~ngcd regioct.1 
function with mainly fibrotic tissue) were not signiticantly 
different in terms of prerevascularization wail motion Score 
index, collateral score index and extent of baseline t chnetium- 
99rn Sestamibi perfusion defect. 0n the contrary, the two 
ups of vascular territories were differentiated preopera- 
cly by the response to the nitrate test. The degree of related 
vessel obstruction was significantly higher in the territories 
with postoperative improvement. This is not surprising because 
tt marked ecrcaSe in coronary blood flow is the rule in the case 
Of hibernating myocardium (1,2), whereas the absence of 
m wstamibi uptake in asynergic territories not 
r&ted to severely steenused v ssels i more likely explained by 
the presence of fibrotic tissue (19,21). 
tionS OF the study. The small patient group is the 
most important limitation of the study, However, this limita- 
iion is shared by most of the studies (22,24-27) dealing with 
the detection of viable hibernating myocardium using 
tehethm@h sestamibi. The strict SeIecLon criteria of the 
patients also meant hat the study cohort mainly inclu 
subjects with severe wall motion abnormalities an
coronary artery di;r;ase. Therefore, studies in a more 
patient population are needed to de 
technetium-99m sestamibi nitrate ima 
quantitative evaluation of the tomog 
pared the count profiles of the baseli 
those of a data base of formal 
tracer uptake were consi 
diwm. Therefore, it is not possible to define the relative 
reliability of tcc~netiu~~l-99m sesta 
sitron emission tomo~rapby or thal 
Further studies are wa~anted to define the value of technetium- 
99m sestamibi nitrate imaging and its role in the management of 
patients with chronic coronas artery disease and left ventricular 
dySfunction. 
WC tbank Raffacle Giubbini, MD, and Owio Zoccarato, MS, of the Nuclear 
Medicine L&oratory of the Brtxia Civic Hospital, Brescia. Italy, for providing 
the data base of normal control subjects. 
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